Ushbu ish iqtibos qilgan ishlar

72 ta ish

Ish: Neurological complications after covid-19 vaccination

Sarlavhasiz
Boshqa8 iqtibos
ABI
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin +26
Maqola20208 iqtibos
ABI
Efficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults
Lianpan Dai, Lidong Gao, Lifeng Tao +27
MaqolaOchiq kirish20227 iqtibos
ABI
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Lindsey R. Baden, Hana M. El Sahly, Brandon Essink +34
Maqola20206 iqtibos
ABI
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Denis Y. Logunov, Inna V. Dolzhikova, Dmitry V. Shcheblyakov +28
Maqola20216 iqtibos
ABI
Nervous system involvement after infection with COVID-19 and other coronaviruses
Yeshun Wu, Xiaolin Xu, Zijun Chen +5
Sharh maqola20205 iqtibos
ABI
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Jerald Sadoff, Glenda Gray, An Vandebosch +27
Maqola20214 iqtibos
ABI
Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans
Claudio Franceschi, Miriam Capri, Daniela Monti +10
Sharh maqola20064 iqtibos
ABI
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael +30
Maqola20203 iqtibos
ABI
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh, Robert W. Frenck, Ann R. Falsey +22
Maqola20203 iqtibos
ABI
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
Tom T. Shimabukuro, Michael Nguyen, David Martin +1
Sharh maqola20153 iqtibos
ABI
The spectrum of post-vaccination inflammatory CNS demyelinating syndromes
Dimitrios Karussis, Panayiota Petrou
Sharh maqola20133 iqtibos
ABI
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
Cristina Menni, Kerstin Kläser, Anna May +25
Maqola20213 iqtibos
ABI
Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding Erythropoietin
Katalin Karikó, Hiromi Muramatsu, Jason M. Keller +1
Maqola20123 iqtibos
ABI
Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases
Maxime Taquet, Masud Husain, John Geddes +2
Maqola20213 iqtibos
ABI
Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2
Javier T. Granados-Riverón, Guillermo Aquino‐Jarquín
Sharh maqola20213 iqtibos
ABI
Improvements in Gene Therapy
Thomas Ritter, Manfred Lehmann, Hans‐Dieter Volk
Sharh maqola20022 iqtibos
ABI
Intravascular adenoviral agents in cancer patients: Lessons from clinical trials
Tony Reid, Robert S. Warren, David H. Kirn
Sharh maqola20022 iqtibos
ABI
Quadrivalent HPV Vaccination and Risk of Multiple Sclerosis and Other Demyelinating Diseases of the Central Nervous System
Nikolai Madrid Scheller, Henrik Svanström, Björn Pasternak +4
Maqola20152 iqtibos
ABI
A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses
Elizabeth S. Gabitzsch, Younong Xu, Lois H. Yoshida +4
Maqola20082 iqtibos
ABI
The influence of innate and pre‐existing immunity on adenovirus therapy
Anne K. Zaiss, Hidevaldo B. Machado, Harvey R. Herschman
Sharh maqola20092 iqtibos
ABI
Epilepsy and vaccinations: Italian guidelines
Dario Pruna, Paolo Balestri, Nelia Zamponi +8
Sharh maqola20132 iqtibos
ABI
Under-Reporting of Adverse Drug Reactions
Lorna Hazell, Saad Shakir
Sharh maqola20062 iqtibos
ABI
Hemostasis factors and aging
Daniela Mari, Raffaella Coppola, Rita Provenzano
Sharh maqola20072 iqtibos
ABI
Liver Toxicities Typically Induced by First-Generation Adenoviral Vectors Can Be Reduced by Use of E1, E2b-Deleted Adenoviral Vectors
Ruth Everett, Bradley L. Hodges, Enyu Ding +3
Maqola20032 iqtibos
ABI